Literature DB >> 16362154

ADPKD: molecular characterization and quest for treatment.

Shigeo Horie1.   

Abstract

Autosomal-dominant polycystic kidney disease (ADPKD) is a common hereditary disease that features multiple cystogenesis in various organs and vascular defects. The genes responsible for ADPKD, PKD1, and PKD2 have been identified, and the pathological processes of the disease are becoming clearer. This review focuses on recent findings about the molecular and cellular biology of ADPKD, and especially on PKD1. PKD1 and its product, polycystin-1, play pivotal roles in cellular differentiation because they regulate the cell cycle and because polycystin-1 is a component of adherens junctions. A possible link between polycystin-1 and PPARgamma is discussed. The extraordinarily fast research progress in this area in the last decade has now reached a stage where the development of a remedy for ADPKD might become possible in the near future.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16362154     DOI: 10.1007/s10157-005-0367-6

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN: 1342-1751            Impact factor:   2.801


  112 in total

Review 1.  Polycystic kidney disease: In danger of being X-rated?

Authors:  J J Grantham; J P Calvet
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-30       Impact factor: 11.205

2.  Left ventricular hypertrophy in autosomal dominant polycystic kidney disease.

Authors:  A B Chapman; A M Johnson; S Rainguet; K Hossack; P Gabow; R W Schrier
Journal:  J Am Soc Nephrol       Date:  1997-08       Impact factor: 10.121

3.  Structure and chromosomal localization of the human constitutive endothelial nitric oxide synthase gene.

Authors:  P A Marsden; H H Heng; S W Scherer; R J Stewart; A V Hall; X M Shi; L C Tsui; K T Schappert
Journal:  J Biol Chem       Date:  1993-08-15       Impact factor: 5.157

4.  Distribution and developmentally regulated expression of murine polycystin.

Authors:  L Geng; Y Segal; A Pavlova; E J Barros; C Löhning; W Lu; S K Nigam; A M Frischauf; S T Reeders; J Zhou
Journal:  Am J Physiol       Date:  1997-04

5.  Polycystin-2 is a novel cation channel implicated in defective intracellular Ca(2+) homeostasis in polycystic kidney disease.

Authors:  P M Vassilev; L Guo; X Z Chen; Y Segal; J B Peng; N Basora; H Babakhanlou; G Cruger; M Kanazirska; E M Brown; M A Hediger; J Zhou
Journal:  Biochem Biophys Res Commun       Date:  2001-03-23       Impact factor: 3.575

6.  The unexpected landscape of in vivo somatic mutation in a human epithelial cell lineage.

Authors:  Lorel M Colgin; Alden F M Hackmann; Mary J Emond; Raymond J Monnat
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-29       Impact factor: 11.205

7.  Polycystin 1 is required for the structural integrity of blood vessels.

Authors:  K Kim; I Drummond; O Ibraghimov-Beskrovnaya; K Klinger; M A Arnaout
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-15       Impact factor: 11.205

Review 8.  Autosomal dominant polycystic kidney disease: clues to pathogenesis.

Authors:  P C Harris
Journal:  Hum Mol Genet       Date:  1999       Impact factor: 6.150

9.  AVP inhibits EGF-stimulated MAP kinase cascade in Madin-Darby canine kidney cells.

Authors:  T Yamada; Y Terada; M K Homma; H Nonoguchi; S Sasaki; Y Yuasa; K Tomita; F Marumo
Journal:  Kidney Int       Date:  1995-09       Impact factor: 10.612

10.  Anion secretion drives fluid secretion by monolayers of cultured human polycystic cells.

Authors:  R Mangoo-Karim; M Ye; D P Wallace; J J Grantham; L P Sullivan
Journal:  Am J Physiol       Date:  1995-09
View more
  2 in total

Review 1.  Autosomal dominant polycystic kidney disease: recent advances in pathogenesis and potential therapies.

Authors:  Toshio Mochizuki; Ken Tsuchiya; Kosaku Nitta
Journal:  Clin Exp Nephrol       Date:  2012-11-29       Impact factor: 2.801

2.  Human Evaluation of the Glu298Asp Polymorphism in NOS3 Gene and its Relationship with Onset age of ESRD in Iranian Patients Suffering from ADPKD.

Authors:  Negin Dasar; Sayyed Mohammad Hossein Ghaderian; Eznollah Azargashb
Journal:  Int J Mol Cell Med       Date:  2012
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.